Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
CC transcript
Appointed director
|
|
CAMBREX CORP (CBM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2019 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"8-K/A",
"Consent of RSM US LLP, Independent Registered Public Accounting Firm (A)",
"Audited Financial Statements of Avista Pharma Solutions, Inc. as of December 31, 2017 and for the year ended December 31, 2017 (A)",
"Unaudited Financial Statements of Avista Pharma Solutions, Inc. as of September 30, 2018 and 2017 and for the nine months ended September 30, 2018 and 2017 (A)",
"Unaudited Pro Forma Condensed Combined Financial Information as of September 30, 2018 and for the nine months ended September 30, 2018 and for the year ended December 31, 2017 (A)" |
|
| 11/26/1997 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 07/17/1995 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 12/29/1994 |
8-K/A
| Form 8-K/A - Current report [Amend] |
|
|